MARDIA SAMYOUNG CAPILLARY TUBES COMPANY LTD.

Mardia Samyoung Capillary Tubes Company Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting will also address any other business matters with the Chair's permission. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mardia Samyoung Capillary Tubes Company Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is effective from July 01, 2026, and will remain in effect until 48 hours after the announcement of the Unaudited Financial Results for the quarter ended June 30, 2026. The company will communicate the date of the board meeting to consider these results in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Mardia Samyoung Capillary Tubes Company Ltd. has announced a change in its Corporate Identification Number (CIN). The revised CIN, as recorded by the Ministry of Corporate Affairs (MCA), is now L20132MH1992PLC069104. The company has requested BSE Limited to update its records with the new CIN, including the BSE listing portal and other relevant databases. A copy of the Master Data from the MCA portal is enclosed as evidence of the change.

Mardia Samyoung Capillary Tubes Company Ltd. announced its audited financial results for the period ended March 31, 2026. The Board of Directors approved the results in their meeting held on May 12, 2026. The financial results include revenue from operations of ₹234.50 lakhs and a net profit of ₹114.72 lakhs for the year ended March 31, 2026. The meeting commenced at 05:00 PM and concluded at 05:30 PM.

Mardia Samyoung Capillary Tubes Company Ltd. has approved the audited financial results for the period ended March 31, 2026, during its Board of Directors meeting held on May 12, 2026. The meeting, which commenced at 05:00 PM and concluded at 05:30 PM, also included the approval of the auditor's report and declarations regarding unmodified opinions and related party transactions. The company has also disclosed information on outstanding defaults on loans and debt securities for the same period. Audited financial results, auditor's report, and related declarations are enclosed with the filing.

Mardia Samyoung Capillary Tubes Company Ltd has scheduled a Board of Directors meeting on May 12, 2026, to consider and approve the audited financial results for the period ended March 31, 2026, along with other business matters.

Mardia Samyoung Capillary Tubes Company Ltd's board approved the appointment of Mr. Ramesh Sharma and Ms. Geetika Garg as Non-Executive Independent Directors, both effective May 06, 2026, for five-year terms, subject to shareholder approval. Simultaneously, Ms. Sonalben Vaghela and Mr. Jaykumar Bhaveshkumar Patel resigned as Non-Executive Independent Directors, effective the same date. Consequently, the Audit Committee, Nomination & Remuneration Committee, and Stakeholder Relationship Committee were reconstituted.

Mardia Samyoung Capillary Tubes Company Ltd's Board of Directors approved the appointment of Mr. Ramesh Sharma and Ms. Geetika Garg as Non-Executive Independent Directors, each for a five-year term effective May 6, 2026, subject to shareholder approval. The board also accepted the resignations of Ms. Sonalben Vaghela and Mr. Jaykumar Bhaveshkumar Patel as Non-Executive Independent Directors, effective the same date. Consequently, the Audit Committee, Nomination & Remuneration Committee, and Stakeholder Relationship Committee were reconstituted.

Mardia Samyoung Capillary Tubes Company Ltd has allotted 3,900,000 equity shares of face value ₹10 each. This allotment is a result of the conversion of 3,900,000 fully convertible equity warrants. These warrants were originally issued on February 6, 2026, to Mr. Gavali Hitendrabhai Bayajebhai, a non-promoter, at an issue price of ₹13.50 per warrant on a preferential basis. Following this allotment, the company's paid-up equity share capital has increased from ₹75,54,80,730 (75,548,073 shares) to ₹79,44,80,730 (79,448,073 shares). The Board of Directors approved this conversion and allotment in a meeting held on April 13, 2026.

Mardia Samyoung Capillary Tubes Company Ltd's Board of Directors approved the allotment of 78,15,000 equity shares, each with a face value of INR 10, on April 11, 2026. These shares were issued following the conversion of 78,15,000 fully convertible equity warrants. The warrants were originally allotted on February 6, 2026, to Mr. Patel Biralkumar Rajeshbhai (39,50,000 warrants) and Mr. Shaikh Sajidbhai Rahimbhai (38,65,000 warrants) at an issue price of INR 13.50 per warrant on a preferential basis to non-promoter categories. Consequently, the company's paid-up equity share capital has increased from INR 67,73,30,730 (6,77,33,073 shares) to INR 75,54,80,730 (7,55,48,073 shares).